Changes in the production of short-chain fatty acids and improvements in gut barrier integrity are linked to enhanced insulin sensitivity and reduced inflammatory markers, essential for effective obesity management. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.